Ye Liu

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Shanghai, China
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Ron Honig, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Ye Liu

Form 4 holding Director

EyePoint Pharmaceuticals, Inc.

Security class
Common Stock, $0.001 par value
Shares / value
100,221
Estimated value
$2,507,088
Report date
11 Jan 2024
Price
$25.02
Ownership
Ocumension Therapeutics

Insider Reports Filed by Ye Liu

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .